article Open AccessTop 1% cited
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Nature Genetics · 2019 · Vol. 51(2) · pp. 202–206
Robert Samstein✉(Memorial Sloan Kettering Cancer Center)Chung‐Han Lee(Memorial Sloan Kettering Cancer Center)Alexander N. Shoushtari(Memorial Sloan Kettering Cancer Center)Matthew D. Hellmann(Memorial Sloan Kettering Cancer Center)Ronglai Shen(Memorial Sloan Kettering Cancer Center)Yelena Y. Janjigian(Memorial Sloan Kettering Cancer Center)David Barron(Memorial Sloan Kettering Cancer Center)Ahmet Zehir(Memorial Sloan Kettering Cancer Center)Emmet Jordan(Memorial Sloan Kettering Cancer Center)Antonio Omuro(Memorial Sloan Kettering Cancer Center)Thomas Kaley(Memorial Sloan Kettering Cancer Center)Sviatoslav M. Kendall(Memorial Sloan Kettering Cancer Center)Robert J. Motzer(Memorial Sloan Kettering Cancer Center)A. Ari Hakimi(Memorial Sloan Kettering Cancer Center)Martin H. Voss(Memorial Sloan Kettering Cancer Center)Paul Russo(Memorial Sloan Kettering Cancer Center)Jonathan E. Rosenberg(Memorial Sloan Kettering Cancer Center)Gopa Iyer(Memorial Sloan Kettering Cancer Center)Bernard H. Bochner(Memorial Sloan Kettering Cancer Center)Dean F. Bajorin(Memorial Sloan Kettering Cancer Center)Hikmat Al‐Ahmadie(Memorial Sloan Kettering Cancer Center)Jamie E. Chaft(Memorial Sloan Kettering Cancer Center)Charles M. Rudin(Memorial Sloan Kettering Cancer Center)Gregory J. Riely(Memorial Sloan Kettering Cancer Center)Shrujal S. Baxi(Memorial Sloan Kettering Cancer Center)Alan L. Ho(Memorial Sloan Kettering Cancer Center)Richard J. Wong(Memorial Sloan Kettering Cancer Center)David G. Pfister(Memorial Sloan Kettering Cancer Center)Jedd D. Wolchok(Memorial Sloan Kettering Cancer Center)Christopher A. Barker(Memorial Sloan Kettering Cancer Center)Philip H. Gutin(Memorial Sloan Kettering Cancer Center)Cameron Brennan(Memorial Sloan Kettering Cancer Center)Viviane Tabar(Memorial Sloan Kettering Cancer Center)Ingo K. Mellinghoff(Memorial Sloan Kettering Cancer Center)Lisa M. DeAngelis(Memorial Sloan Kettering Cancer Center)Charlotte E. Ariyan(Memorial Sloan Kettering Cancer Center)Nancy Y. Lee(Memorial Sloan Kettering Cancer Center)William D. Tap(Memorial Sloan Kettering Cancer Center)Mrinal M. Gounder(Memorial Sloan Kettering Cancer Center)Sandra P. D’Angelo(Cornell University)Leonard B. Saltz(Memorial Sloan Kettering Cancer Center)Zsofia K. Stadler(Memorial Sloan Kettering Cancer Center)Howard I. Scher(Memorial Sloan Kettering Cancer Center)José Baselga(Memorial Sloan Kettering Cancer Center)Pedram Razavi(Memorial Sloan Kettering Cancer Center)Christopher A. Klebanoff(Memorial Sloan Kettering Cancer Center)Rona Yaeger(Memorial Sloan Kettering Cancer Center)Neil H. Segal(Memorial Sloan Kettering Cancer Center)Geoffrey Y. Ku(Memorial Sloan Kettering Cancer Center)Ronald P. DeMatteo(Memorial Sloan Kettering Cancer Center)Marc Ladanyi(Memorial Sloan Kettering Cancer Center)Naiyer A. Rizvi(Columbia University Irving Medical Center)Michael F. Berger(Memorial Sloan Kettering Cancer Center)Nadeem Riaz(Memorial Sloan Kettering Cancer Center)David B. Solit(Memorial Sloan Kettering Cancer Center)Timothy A. Chan(Memorial Sloan Kettering Cancer Center)Luc G.T. Morris(Memorial Sloan Kettering Cancer Center)
Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsBiologyCancerOncologyImmunotherapyInternal medicineOverall survivalSurvival analysisSomatic cellCancer researchMedicine
MeSH terms
Antineoplastic AgentsHumansImmunotherapyMutationNeoplasmsTumor BurdenHigh-Throughput Nucleotide Sequencing
Citations
4,300
FWCI
247.64
field-weighted impact
References
34
Percentile
100%
vs. same field & year
Citations per year
Cited by
STING Agonists as Cancer Therapeutics
Cancers · 2021 · 371 citations
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
Annals of Oncology · 2021 · 1,029 citations
Top 10 Challenges in Cancer Immunotherapy
Immunity · 2020 · 2,223 citations
References
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
New England Journal of Medicine · 2015 · 9,308 citations
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Science · 2015 · 7,864 citations
Signatures of mutational processes in human cancer
Nature · 2013 · 10,018 citations
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
New England Journal of Medicine · 2012 · 12,531 citations
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
The Lancet Oncology · 2016 · 1,657 citations
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Nature Medicine · 2017 · 3,455 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
